View More Recent Stories
-
Intercept Pharma (ICPT) Prices 1M Common Offering at $320/Share
-
Intercept Pharmaceuticals Announces Pricing of Public Offering
-
Intercept Pharma (ICPT) to Offer 1M Shares
-
Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
UPDATE: Intercept Pharmaceuticals (ICPT) PT Raised to $700 at Citi on Mitigated Safety Concerns
-
Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)
-
UPDATE: Intercept (ICPT) Price Target Raised to $600 at Citi, Analyst Comments on LDL Increase
-
Citi Starts Intercept Pharmaceuticals (ICPT) at Buy
-
Intercept Pharma (ICPT) Prices 1.73M Common Offering at $33.01/Share
-
Notable Analyst Rating Changes 11/12: (SQNM) (DIS) (KLAC) Upgraded; (GRMN) (JCP) (SD) Downgraded

